Education DIMENSIONChagas Disease CardiomyopathyJimenez, Ariana MSN, AGACNP-BC; Winokur, Elizabeth J. PhD, RN, CEN Author Information Ariana Jimenez, MSN, AGACNP-BC, is a recent graduate of California State University Los Angeles. She currently works as a cardiothoracic surgery nurse practitioner at Long Beach Memorial Medical Center in Long Beach, California. Elizabeth J. Winokur, PhD, RN, CEN, is associate professor and associate director, Patricia A. Chin School of Nursing, California State University Los Angeles; and nurse researcher, Providence St Joseph Hospital, Orange. The authors have disclosed that they have no significant relationship with, or financial interest in, any commercial companies pertaining to this article. Address correspondence and reprint requests to: Ariana Jimenez, MSN, AGACNP-BC, Long Beach Medical Center, 2801 Atlantic Ave, Long Beach, CA 90807 ([email protected]; [email protected]). Dimensions of Critical Care Nursing 42(4):p 202-210, 7/8 2023. | DOI: 10.1097/DCC.0000000000000590 Buy Metrics Abstract Abstract Chagas disease is a prominent neglected tropical disease endemic to many countries in Latin America. Cardiomyopathy is the most serious manifestation due to the severity and complications of heart failure. As a result of expanded immigration and globalization, there is an increased number of patients with Chagas cardiomyopathy who are being admitted to hospitals in the United States. It is imperative as a critical care nurse to be educated on the nature of Chagas cardiomyopathy as it differs from the more commonly seen ischemic and nonischemic forms. This article provides an overview of the clinical course, management, and treatment options of Chagas cardiomyopathy. Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.